Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sonazoid CEUS for Sentinel Lymph Node Detection in Breast Cancer
NCT02652923Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Jan 2016
- Primary completion
- Jan 2022
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of sonazoid in breast cancer, sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Jan 2016; status: completed.
02
Drugs
sonazoid
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02652923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02652923.